Other substances

Ginkgetin

A biflavonoid.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
3
 AI-suggested references
0
 Clinical trials

General information

Ginkgetin on PubChem

 

Structure image - Ginkgetin

COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C=C(C=C3O2)OC)O)C4=C(C=C(C5=C4OC(=CC5=O)C6=CC=C(C=C6)O)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Computer aided identification of potential SARS CoV-2 main protease inhibitors from diterpenoids and biflavonoids of Torreya nucifera leaves
3CLpro Small molecule In silico 		in silico 3.22

Predicted to have a higher binding affinity to the SARS-CoV-2 3C-like protease than N3 or lopinavir.

 Nov/03/2020

AI-suggested references

Link Publication date
Repurposing of anticancer phytochemicals for identifying potential fusion inhibitor for SARS-CoV-2 using molecular docking and molecular dynamics (MD) simulations.
Mar/22/2021
Natural biflavonoids as potential therapeutic agents against microbial diseases.
Mar/20/2021
In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis.
Nov/25/2020
Export (.csv)